2006
DOI: 10.1016/j.bmc.2006.01.062
|View full text |Cite
|
Sign up to set email alerts
|

Tricyclic pharmacophore-based molecules as novel integrin αvβ3 antagonists. Part IV: Preliminary control of αvβ3 selectivity by meta-oriented substitution

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0
1

Year Published

2007
2007
2023
2023

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 17 publications
(13 citation statements)
references
References 14 publications
0
12
0
1
Order By: Relevance
“…The poly­(ethylene glycol) (PEG) derivatives 2-(2-(2-(2-azidoethoxy)­ethoxy)­ethoxy)­ethylamine (NH 2 -PEG 4 -N 3 ) and 2-(2-(2-(2-azidoethoxy)­ethoxy)­ethoxy)­ethylmethanesulfonate (MsO-PEG 4 -N 3 ) were synthesized according to recently described procedures . Lead compound 5 was synthesized as shown in Scheme and reported in the literature . The RGD peptide used for blocking studies ( cyclo -[C RGD C]­GK) was purchased from Bachem (Bubendorf, Switzerland) and has been used before. , Nuclear magnetic resonance (NMR) spectra ( 1 H, 13 C and 19 F) were recorded on a Bruker AV 300 or AV 400 instrument (Bruker BioSpin GmbH, Rheinstetten, Germany) or an Agilent DD2 600 instrument (Agilent Technologies Deutschland GmbH, Boeblingen, Germany), respectively.…”
Section: Methodsmentioning
confidence: 99%
“…The poly­(ethylene glycol) (PEG) derivatives 2-(2-(2-(2-azidoethoxy)­ethoxy)­ethoxy)­ethylamine (NH 2 -PEG 4 -N 3 ) and 2-(2-(2-(2-azidoethoxy)­ethoxy)­ethoxy)­ethylmethanesulfonate (MsO-PEG 4 -N 3 ) were synthesized according to recently described procedures . Lead compound 5 was synthesized as shown in Scheme and reported in the literature . The RGD peptide used for blocking studies ( cyclo -[C RGD C]­GK) was purchased from Bachem (Bubendorf, Switzerland) and has been used before. , Nuclear magnetic resonance (NMR) spectra ( 1 H, 13 C and 19 F) were recorded on a Bruker AV 300 or AV 400 instrument (Bruker BioSpin GmbH, Rheinstetten, Germany) or an Agilent DD2 600 instrument (Agilent Technologies Deutschland GmbH, Boeblingen, Germany), respectively.…”
Section: Methodsmentioning
confidence: 99%
“…CP4715, an α V β 3 integrin inhibitor, was prepared as previously described [18][19][20][21]. In some experiments, MRC-5 cells and IPF lung fibroblasts were treated with 1 μM CP4715 dissolved in DMSO for 24 h.…”
Section: Transient Transfectionmentioning
confidence: 99%
“…Discarding those compounds with unspecified antagonistic activity and the chemicals with undefined stereochemistry, a total of 102 tricyclic piperazine or piperidine furnished molecules with a wide spectrum of antiplatelet activities against dual ␣ v ␤ 3 and ␣ IIb ␤ 3 receptors were collected from the work of D. Kubota et al and used as the dataset for molecular modeling in this study [2,10,24,25]. In this work, the in vitro biological activities of these compounds were converted into the corresponding pIC 50 (−log IC 50 ) values, which were used as dependent variables in the QSAR analyses.…”
Section: Dataset and Biological Activitymentioning
confidence: 99%